Hookipa Pharma Inc (HOOK) Earnings Report, Financial Results, Financial analysis

Hookipa Pharma inc narrowed IV. Quarter net loss per share of $-0.11 compare to net loss per share of $-0.68 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.25 realized in previous quarter.

*IV. Quarter*
Earnings Per Share	Revenues
$ -0.11	$ 8 Mill
$+0.57	$+4M +109.92 %

Hookipa Pharma Inc 's Revenue rose by 109.92 % in IV. Quarter (Dec 31 2022) year on year, to $8 million and advanced by 251.03 % sequentially.

Hookipa Pharma Inc is Expected to report next financial results on May 01, 2023.

More on HOOK's Income Statement

HOOK's NET INCOME

Hookipa Pharma Inc 's in IV. Quarter recorded net loss of $-12.311 million, an improvement compare to net loss of $-27.685 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-18.280 million realized in previous quarter.

More on HOOK's Growth

Hookipa Pharma Inc Inventories
HOOK's Cash flow In IV. Quarter company's net cash flow was $12 million, capital expenditures grew by -92.15%, to $-1 millions compare to same quarter a year ago and rose by -37.47% from III. Quarter (Sep 30 2022).

More on HOOK's Cash flow Statement

Earnings quality

Hookipa Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Hookipa Pharma inc payed $ -0.30 cash per share, on a free-cash flow basis .

Book value grew by 0.86 % sequentially to $1.56 per share.
Tangible Book value grew to $ 1.56 per share from $ 1.55.

Company repurchased 7.55 million shares or 10.32 % in IV. Quarter.

• More on HOOK's Dividends

Market Capitalization (Millions)	48
Shares Outstanding (Millions)	66
Total Debt (Millions $)	3
Revenue (TTM) (Millions $)	14
Net Income (TTM) (Millions $)	-65
Cash Flow (TTM) (Millions $)	47
Capital Exp. (TTM) (Millions $)	-5
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-

Earnings quality

Hookipa Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Hookipa Pharma inc had negative $ -0.30 cash flow per share, on a free-cash flow basis .

Book value grew by 0.86 % sequentially to $1.56 per share.
Tangible Book value grew to $ 1.56 per share from $ 1.55.

Company repurchased 7.55 million shares or 10.32 % in IV. Quarter.

• More on HOOK's Balance Sheets

Market Capitalization (Millions)	48
Shares Outstanding (Millions)	66
Total Debt (Millions $)	3
Revenue (TTM) (Millions $)	14
Net Income (TTM) (Millions $)	-65
Cash Flow (TTM) (Millions $)	47
Capital Exp. (TTM) (Millions $)	-5
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Employees (TTM) $	-


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MSC's Profile Stock Price MSC's Financials Business Description Fundamentals Charts & Quotes MSC's News Suppliers MSC's Competitors Customers & Markets Economic Indicators MSC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Hookipa Pharma inc

HOOK's Financial Statements and Analysis